🇺🇸 Rosuvastatin 20mg in United States

39 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Rash — 7 reports (17.95%)
  2. Capsular Warning Syndrome — 4 reports (10.26%)
  3. Death — 4 reports (10.26%)
  4. Myalgia — 4 reports (10.26%)
  5. Pain In Extremity — 4 reports (10.26%)
  6. Peripheral Swelling — 4 reports (10.26%)
  7. Asthenia — 3 reports (7.69%)
  8. Fatigue — 3 reports (7.69%)
  9. Insomnia — 3 reports (7.69%)
  10. Off Label Use — 3 reports (7.69%)

Source database →

Rosuvastatin 20mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Rosuvastatin 20mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Rosuvastatin 20mg in United States?

AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.